WO1999057273A3 - Sequences de codage antiproteinase-3 cytoplasmique en therapie genique - Google Patents
Sequences de codage antiproteinase-3 cytoplasmique en therapie genique Download PDFInfo
- Publication number
- WO1999057273A3 WO1999057273A3 PCT/US1999/008949 US9908949W WO9957273A3 WO 1999057273 A3 WO1999057273 A3 WO 1999057273A3 US 9908949 W US9908949 W US 9908949W WO 9957273 A3 WO9957273 A3 WO 9957273A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- coding sequence
- gene therapy
- cytoplasmic antiproteinase
- antiproteinase
- cytoplasmic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8121—Serpins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU38667/99A AU3866799A (en) | 1998-05-04 | 1999-04-27 | Cytoplasmic antiproteinase-3 coding sequence in gene therapy |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7227598A | 1998-05-04 | 1998-05-04 | |
US09/072,275 | 1998-05-04 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1999057273A2 WO1999057273A2 (fr) | 1999-11-11 |
WO1999057273A3 true WO1999057273A3 (fr) | 2000-01-20 |
Family
ID=22106607
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/008949 WO1999057273A2 (fr) | 1998-05-04 | 1999-04-27 | Sequences de codage antiproteinase-3 cytoplasmique en therapie genique |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU3866799A (fr) |
WO (1) | WO1999057273A2 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2514395A1 (fr) * | 2003-02-19 | 2005-07-28 | University Of Chicago | Procedes et compositions pour inhiber des cathepsines |
GB201804514D0 (en) | 2018-03-21 | 2018-05-02 | Ucl Business Plc | Treatment of pyroptosis |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5612194A (en) * | 1989-06-23 | 1997-03-18 | Trustees Of The University Of Pennsylvania | Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors |
US5710026A (en) * | 1995-02-08 | 1998-01-20 | Zymogenetics, Inc. | Cytoplasmic antiproteinase-2 and cytoplasmic antiproteinase-3 and coding sequences |
WO1998011129A1 (fr) * | 1996-09-12 | 1998-03-19 | Idun Pharmaceuticals, Incorporated | DIPEPTIDES DE (N-SUBSTITUE)-2-INDOLYLE A MODIFICATION C-TERMINALE UTILISES EN TANT QU'INHIBITEURS DE LA FAMILLE ICE/ced-3 DE CYSTEINE PROTEASES |
-
1999
- 1999-04-27 AU AU38667/99A patent/AU3866799A/en not_active Abandoned
- 1999-04-27 WO PCT/US1999/008949 patent/WO1999057273A2/fr active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5612194A (en) * | 1989-06-23 | 1997-03-18 | Trustees Of The University Of Pennsylvania | Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors |
US5710026A (en) * | 1995-02-08 | 1998-01-20 | Zymogenetics, Inc. | Cytoplasmic antiproteinase-2 and cytoplasmic antiproteinase-3 and coding sequences |
WO1998011129A1 (fr) * | 1996-09-12 | 1998-03-19 | Idun Pharmaceuticals, Incorporated | DIPEPTIDES DE (N-SUBSTITUE)-2-INDOLYLE A MODIFICATION C-TERMINALE UTILISES EN TANT QU'INHIBITEURS DE LA FAMILLE ICE/ced-3 DE CYSTEINE PROTEASES |
Non-Patent Citations (3)
Title |
---|
GAGLIARDINI V ET AL: "Prevention of vertebrate neuronal death by the crmA gene", SCIENCE, vol. 263, 11 February 1994 (1994-02-11), pages 826 - 828, XP002122713 * |
NICHOLSON DW ET AL: "Caspases: killer proteases", TIBS, vol. 22, August 1997 (1997-08-01), pages 299 - 306, XP002122715 * |
ROUQUET N ET AL: "ICE inhibitor YVADcmk is a potent therapeutic agent against in vivo liver apoptosis.", CURRENT BIOLOGY, (1996 SEP 1) 6 (9) 1192-5., XP002122714 * |
Also Published As
Publication number | Publication date |
---|---|
AU3866799A (en) | 1999-11-23 |
WO1999057273A2 (fr) | 1999-11-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1996024650A3 (fr) | L'antiproteinase-2 cytoplasmique et l'antiproteinase-3 cytoplasmique et leurs sequences de codage | |
WO2003000840A3 (fr) | Nitrilases | |
WO2003023008A8 (fr) | Polypeptides therapeutiques, acides nucleiques les codant, et modalites d'emploi correspondantes | |
FI964174A0 (fi) | Menetelmät tehokkaisen yhdistelmä-DNA-seriiniproteaasi-inhibiittoreiden tuottamiseksi ja näiden inhibiittorien käyttöjä | |
AU2001236638A1 (en) | Evi27 gene sequences and protein encoded thereby | |
WO2000053776A3 (fr) | Nouveaux genes humains du type kallikreine | |
AU2002357004A1 (en) | Nucleic acid molecules encoding serine protease 17, the encoded polypeptides and methods based thereon | |
AU2002214542A1 (en) | Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof | |
AU2003259246A1 (en) | Methods for the use of neurotoxin in the treatment of urologic disorders | |
EP1244780A4 (fr) | Adn codant la serine protease t humaine | |
WO1999057273A3 (fr) | Sequences de codage antiproteinase-3 cytoplasmique en therapie genique | |
AU2003217956A1 (en) | Therapeutic polypeptides, nucleic acids encoding same and methods of use | |
WO2003040330A8 (fr) | Polypeptides therapeutiques, acides nucleiques les codant et procedes d'utilisation correspondant | |
AU2001288363A1 (en) | Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof | |
AU2002258630A1 (en) | Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof | |
EP1045914B8 (fr) | Svph1-8 proteinase humaine specifique aux testicules | |
AU2001268108A1 (en) | Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders | |
AU2002229060A1 (en) | Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof | |
AU2003298570A1 (en) | Isolated human hepsin/46 proteins, nucleic acid molecules encoding human hepsin/46 proteins, and uses thereof | |
EP1383871A4 (fr) | Proteines enzymatiques humaines isolees, molecules d'acides nucleiques codant pour ces proteines, et leurs utilisations | |
AU2002303137A1 (en) | Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof | |
EP1379678A4 (fr) | Proteines isolees humaines de la protease, molecules d'acide nucleique codant les proteines humaines de la protease et leurs utilisations | |
AU2002365216A1 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
AU2003304034A1 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
WO2003060149A9 (fr) | Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et procedes d'utilisation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
NENP | Non-entry into the national phase |
Ref country code: KR |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase |